In Vitro Selection of Highly Darunavir-Resistant and Replication-Competent HIV-1 Variants by Using a Mixture of Clinical HIV-1 Isolates Resistant to Multiple Conventional Protease Inhibitors

Benzer Materyaller

• Loss of Protease Dimerization Inhibition Activity of Darunavir Is Associated with the Acquisition of Resistance to Darunavir by HIV-1
  Yazar:: Koh, Yasuhiro, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Loss of the Protease Dimerization Inhibition Activity of Tipranavir (TPV) and Its Association with the Acquisition of Resistance to TPV by HIV-1
  Yazar:: Aoki, Manabu, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• GRL-04810 and GRL-05010, Difluoride-Containing Nonpeptidic HIV-1 Protease Inhibitors (PIs) That Inhibit the Replication of Multi-PI-Resistant HIV-1 In Vitro and Possess Favorable Lipophilicity That May Allow Blood-Brain Barrier Penetration
  Yazar:: Salcedo Gómez, Pedro Miguel, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• GRL-02031, a Novel Nonpeptidic Protease Inhibitor (PI) Containing a Stereochemically Defined Fused Cyclopentanyltetrahydrofuran Potent against Multi-PI-Resistant Human Immunodeficiency Virus Type 1 In Vitro
  Yazar:: Koh, Yasuhiro, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Novel HIV-1 Protease Inhibitors (PIs) Containing a Bicyclic P2 Functional Moiety, Tetrahydropyrano-Tetrahydrofuran, That Are Potent against Multi-PI-Resistant HIV-1 Variants
  Yazar:: Ide, Kazuhiko, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)